MarketPeel
Insider Trading Intelligence
RH

Robert Hershberg

ADPT
DIRECTOR · ADAPTIVE BIOTECHNOLOGIES CORP · CIK 0001274139
FILING MIX · LIFETIME56%/44%
BUYS
57
SELLS
44
TOTAL VALUE
$3.37M
COMPANIES
4
ACTIVE SINCE
Feb 2020
HOLDINGS NOW
313,361
AVG SELL PX
$14.12
TRADE KIND
SHOWING 101 / 101
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
20 backtested trades · 8 horizons · 3 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Robert Hershberg, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d20+35.00%+1.67%+1.02%+0.65%+1.81%
14d20+30.00%-0.05%+1.06%-1.12%-1.26%
30d20+25.00%+7.14%+3.04%+4.10%+9.03%
60d20+40.00%+8.61%+6.66%+1.95%+1.80%
90d20+40.00%+4.91%+9.79%-4.88%-9.09%
180d20+35.00%+13.86%+17.62%-3.76%+5.71%
1y20(1 pending)+89.47%-26.58%+32.15%-58.73%-58.83%
2y20(2 pending)+100.00%-79.70%+24.91%-104.61%-101.57%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
ADPT · 62,347 shares · as of Mar 4, 2026
030,67361,34592,018122,690202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
2026
FLOW · 57 buys / 44 sellsCOVERAGE · 27 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
ATAI
ATAIBECKLEY INC.
SALE
48,85848,858Jul 7, 2026Jul 9, 2026View →
ATAI
ATAIBECKLEY INC.
PURCHASE
48,858$1.35$66.0K48,858Jul 7, 2026Jul 9, 2026View →
ATAI
ATAIBECKLEY INC.
SALE
51,142404,869Jul 7, 2026Jul 9, 2026View →
ATAI
ATAIBECKLEY INC.
SALE10b5-1
10b5-1 plan
100,000$4.96$496.0K100,000Jul 7, 2026Jul 9, 2026View →
ATAI
ATAIBECKLEY INC.
PURCHASE
51,142$1.35$69.0K100,000Jul 7, 2026Jul 9, 2026View →
RXRX
RECURSION PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
88,424162,156Jun 17, 2026Jun 22, 2026View →
ATAI
ATAIBECKLEY INC.
PURCHASEGRANT
Stock grant
121,968121,968Jun 4, 2026Jun 8, 2026View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
PURCHASEGRANT
Stock grant
15,62562,347Mar 4, 2026Mar 6, 2026View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
22,968$16.00$367.5K46,722Dec 10, 2025Dec 12, 2025View →
ATAI
ATAIBECKLEY INC.
PURCHASEGRANT
Stock grant
456,011456,011Nov 5, 2025Nov 6, 2025View →
ATAI
ATAIBECKLEY INC.
PURCHASEGRANT
Stock grant
62,39462,394Nov 5, 2025Nov 6, 2025View →
ATAI
ATAIBECKLEY INC.
PURCHASEGRANT
Stock grant
97,71697,716Nov 5, 2025Nov 6, 2025View →
ATAI
ATAIBECKLEY INC.
PURCHASEGRANT
Stock grant
103,000103,000Nov 5, 2025Nov 6, 2025View →
RXRX
RECURSION PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
22,01673,732Jun 18, 2025Jun 23, 2025View →
RXRX
RECURSION PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
44,03144,031Jun 18, 2025Jun 23, 2025View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
53,000$7.59$402.3K69,690Mar 12, 2025Mar 12, 2025View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
PURCHASEGRANT
Stock grant
15,394122,690Mar 4, 2025Mar 6, 2025View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
PURCHASEGRANT
Stock grant
23,72623,726Mar 4, 2025Mar 6, 2025View →
RXRX
RECURSION PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
13,09751,716Jun 3, 2024Jun 5, 2024View →
RXRX
RECURSION PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
26,19326,193Jun 3, 2024Jun 5, 2024View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
PURCHASEGRANT
Stock grant
48,04448,044Mar 4, 2024Mar 6, 2024View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
PURCHASEGRANT
Stock grant
31,328107,296Mar 4, 2024Mar 6, 2024View →
RXRX
RECURSION PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
25,22425,224Jun 16, 2023Jun 21, 2023View →
RXRX
RECURSION PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
12,61238,619Jun 16, 2023Jun 21, 2023View →
FATE
FATE THERAPEUTICS INC
PURCHASEGRANT
Stock grant
40,00040,000Jun 6, 2023Jun 7, 2023View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
PURCHASEGRANT
Stock grant
23,32923,329Mar 6, 2023Mar 8, 2023View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
PURCHASEGRANT
Stock grant
14,77575,968Mar 6, 2023Mar 8, 2023View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
PURCHASE
53,000$0.45$23.9K61,193Feb 2, 2023Feb 3, 2023View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
53,0000Feb 2, 2023Feb 3, 2023View →
RXRX
RECURSION PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
18,14526,007Jun 14, 2022Jun 16, 2022View →
RXRX
RECURSION PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
36,29036,290Jun 14, 2022Jun 16, 2022View →
FATE
FATE THERAPEUTICS INC
PURCHASEGRANT
Stock grant
8,65010,659Jun 9, 2022Jun 13, 2022View →
FATE
FATE THERAPEUTICS INC
PURCHASEGRANT
Stock grant
11,89311,893Jun 9, 2022Jun 13, 2022View →
FATE
FATE THERAPEUTICS INC
SALE
672$22.75$15.3K2,009Jun 3, 2022Jun 6, 2022View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
PURCHASEGRANT
Stock grant
16,72216,722Jan 26, 2022Jan 28, 2022View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
PURCHASEGRANT
Stock grant
6,6898,193Jan 26, 2022Jan 28, 2022View →
RXRX
RECURSION PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
6937,862Jan 3, 2022Jan 5, 2022View →
RXRX
RECURSION PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
5727,169Oct 1, 2021Oct 5, 2021View →
RXRX
RECURSION PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
3476,597Jul 1, 2021Jul 6, 2021View →
FATE
FATE THERAPEUTICS INC
PURCHASEGRANT
Stock grant
2,6812,681Jun 2, 2021Jun 4, 2021View →
FATE
FATE THERAPEUTICS INC
PURCHASEGRANT
Stock grant
4,3344,334Jun 2, 2021Jun 4, 2021View →
RXRX
RECURSION PHARMACEUTICALS, INC.
SALE
525,0000Apr 20, 2021Apr 22, 2021View →
RXRX
RECURSION PHARMACEUTICALS, INC.
SALE
12,5000Apr 20, 2021Apr 22, 2021View →
RXRX
RECURSION PHARMACEUTICALS, INC.
PURCHASE
12,50012,500Apr 20, 2021Apr 22, 2021View →
RXRX
RECURSION PHARMACEUTICALS, INC.
PURCHASE
525,000525,000Apr 20, 2021Apr 22, 2021View →
RXRX
RECURSION PHARMACEUTICALS, INC.
PURCHASE
6,2506,250Apr 20, 2021Apr 22, 2021View →
RXRX
RECURSION PHARMACEUTICALS, INC.
SALE
6,2500Apr 20, 2021Apr 22, 2021View →
RXRX
RECURSION PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
6,2506,250Apr 16, 2021Apr 19, 2021View →
RXRX
RECURSION PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
12,50012,500Apr 15, 2021Apr 19, 2021View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
2,00053,000Mar 8, 2021Mar 10, 2021View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
PURCHASE
2,000$0.45$9002,000Mar 8, 2021Mar 10, 2021View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
2,000$44.56$89.1K0Mar 8, 2021Mar 10, 2021View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
2,00053,000Mar 8, 2021Mar 10, 2021View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
2,000$44.56$89.1K1,504Mar 8, 2021Mar 10, 2021View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
PURCHASE
2,000$0.45$9003,504Mar 8, 2021Mar 10, 2021View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
2,000$65.45$130.9K1,504Feb 16, 2021Feb 17, 2021View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
PURCHASE
2,000$0.45$9003,504Feb 16, 2021Feb 17, 2021View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
2,00055,000Feb 16, 2021Feb 17, 2021View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
PURCHASEGRANT
Stock grant
1,5041,504Feb 14, 2021Feb 17, 2021View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
PURCHASEGRANT
Stock grant
3,7593,759Feb 14, 2021Feb 17, 2021View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
2,00057,000Jan 15, 2021Jan 20, 2021View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
622$67.05$41.7K0Jan 15, 2021Jan 20, 2021View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
PURCHASE
2,000$0.45$9002,000Jan 15, 2021Jan 20, 2021View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
1,378$66.34$91.4K622Jan 15, 2021Jan 20, 2021View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
241$57.01$13.7K0Dec 15, 2020Dec 16, 2020View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
2,00059,000Dec 15, 2020Dec 16, 2020View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
PURCHASE
2,000$0.45$9002,000Dec 15, 2020Dec 16, 2020View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
1,759$55.78$98.1K241Dec 15, 2020Dec 16, 2020View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
1,777$47.60$84.6K223Nov 16, 2020Nov 18, 2020View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
PURCHASE
2,000$0.45$9002,000Nov 16, 2020Nov 18, 2020View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
223$48.41$10.8K0Nov 16, 2020Nov 18, 2020View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
2,00061,000Nov 16, 2020Nov 18, 2020View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
2,000$51.51$103.0K0Oct 15, 2020Oct 16, 2020View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
2,00063,000Oct 15, 2020Oct 16, 2020View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
PURCHASE
2,000$0.45$9002,000Oct 15, 2020Oct 16, 2020View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
2,000$42.58$85.2K0Sep 15, 2020Sep 16, 2020View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
2,00065,000Sep 15, 2020Sep 16, 2020View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
PURCHASE
2,000$0.45$9002,000Sep 15, 2020Sep 16, 2020View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
1,439$39.13$56.3K561Aug 17, 2020Aug 19, 2020View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
2,00067,000Aug 17, 2020Aug 19, 2020View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
561$40.04$22.5K0Aug 17, 2020Aug 19, 2020View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
PURCHASE
2,000$0.45$9002,000Aug 17, 2020Aug 19, 2020View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
2,00069,000Jul 15, 2020Jul 17, 2020View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
PURCHASE
2,000$0.45$9002,000Jul 15, 2020Jul 17, 2020View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
500$44.58$22.3K0Jul 15, 2020Jul 17, 2020View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
1,500$43.60$65.4K500Jul 15, 2020Jul 17, 2020View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
984$43.42$42.7K0Jun 15, 2020Jun 17, 2020View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
PURCHASE
2,000$0.45$9002,000Jun 15, 2020Jun 17, 2020View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
1,016$42.59$43.3K984Jun 15, 2020Jun 17, 2020View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
2,00071,000Jun 15, 2020Jun 17, 2020View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
2,00073,000May 15, 2020May 18, 2020View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
1,202$34.14$41.0K798May 15, 2020May 18, 2020View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
PURCHASE
2,000$0.45$9002,000May 15, 2020May 18, 2020View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
400$35.23$14.1K398May 15, 2020May 18, 2020View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
398$36.10$14.4K0May 15, 2020May 18, 2020View →
FATE
FATE THERAPEUTICS INC
PURCHASEGRANT
Stock grant
16,00016,000May 1, 2020May 5, 2020View →
FATE
FATE THERAPEUTICS INC
PURCHASEGRANT
Stock grant
24,00024,000May 1, 2020May 5, 2020View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
25,00075,000Apr 23, 2020Apr 27, 2020View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
PURCHASE
25,000$0.45$11.3K25,000Apr 23, 2020Apr 27, 2020View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
SALE
25,000$29.77$744.3K0Apr 23, 2020Apr 27, 2020View →
ADPT
ADAPTIVE BIOTECHNOLOGIES CORP
PURCHASEGRANT
Stock grant
8,8888,888Feb 13, 2020Feb 18, 2020View →
Other insiders · ADPT
Loading peer insiders…
About this filer
CIK 0001274139
ROLE
Director
PRIMARY
ADPT
COMPANIES
4
ACTIVE SINCE
Feb 2020
MARKETPEEL · /INSIDER/0001274139DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback